Latest Insider Transactions at Nurix Therapeutics, Inc. (NRIX)
This section provides a real-time view of insider transactions for Nurix Therapeutics, Inc. (NRIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nurix Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nurix Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2020
|
Gwenn Hansen Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$0
$0.84 P/Share
|
|
Jul 28
2020
|
Redmile Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,176,470
+50.0%
|
-
|
|
Jul 28
2020
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
5,422,549
+32.1%
|
-
|
|
Jul 28
2020
|
Column Group L P > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
6,672,548
+44.64%
|
-
|